Literature DB >> 17316625

Intermittent fasting prevents the progression of type I diabetic nephropathy in rats and changes the expression of Sir2 and p53.

Kulbhushan Tikoo1, Durga Nand Tripathi, Dhiraj G Kabra, Vikram Sharma, Anil Bhanudas Gaikwad.   

Abstract

Diabetic nephropathy (DN) is one of the main causes of end stage renal disease (ESRD) and a leading cause of diabetes mellitus related morbidity and mortality. Recently, sirtuin are reported to have emerging pathogenetic roles in cancer, muscle differentiation, heart failure, neurodegeneration, diabetes and aging. The aim of the present study was to study the role of intermittent fasting (IF) on DN and studying the expression of Sir2 and p53. At biochemical level, we found that IF causes significant improvement in blood urea nitrogen (BUN), creatinine, albumin and HDL cholesterol, parameters that are associated with the development of DN. Diabetic rats on IF also show significant improvement in onset of hypertension. Interestingly, the expression of Sir2, a NAD dependent histone deacetylase, decreases in diabetic rat kidney and this decrease is overcome by IF. Moreover, we provide evidence for involvement of mitogen activated protein kinases (MAPK) cascade in mediating the effects of IF as there is reduction in the expression of p38 which gets induced under diabetic condition. This was further accompanied by the concomitant decrease in cleavage of caspase3 and p53 expression. These findings suggest that IF significantly improves biochemical parameters associated with development of DN and changes the expression of Sir2 and p53.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17316625     DOI: 10.1016/j.febslet.2007.02.006

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  42 in total

Review 1.  Role of nitrosative stress in the pathogenesis of diabetic vascular dysfunction.

Authors:  Csaba Szabo
Journal:  Br J Pharmacol       Date:  2009-02-06       Impact factor: 8.739

Review 2.  Interventions against nutrient-sensing pathways represent an emerging new therapeutic approach for diabetic nephropathy.

Authors:  Daisuke Koya; Munehiro Kitada; Shinji Kume; Keizo Kanasaki
Journal:  Clin Exp Nephrol       Date:  2013-11-14       Impact factor: 2.801

Review 3.  Calorie restriction in rodents: Caveats to consider.

Authors:  Donald K Ingram; Rafael de Cabo
Journal:  Ageing Res Rev       Date:  2017-06-10       Impact factor: 10.895

4.  Resveratrol up-regulates SIRT1 and inhibits cellular oxidative stress in the diabetic milieu: mechanistic insights.

Authors:  Jung-Mi Yun; Alexander Chien; Ishwarlal Jialal; Sridevi Devaraj
Journal:  J Nutr Biochem       Date:  2011-08-02       Impact factor: 6.048

Review 5.  Pharmacological modulation of autophagy: therapeutic potential and persisting obstacles.

Authors:  Lorenzo Galluzzi; José Manuel Bravo-San Pedro; Beth Levine; Douglas R Green; Guido Kroemer
Journal:  Nat Rev Drug Discov       Date:  2017-05-19       Impact factor: 84.694

6.  Modulation of histone deacetylase attenuates naloxone-precipitated opioid withdrawal syndrome.

Authors:  Ashish K Rehni; Nirmal Singh; Mahesh Rachamalla; Kulbhushan Tikoo
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2012-02-25       Impact factor: 3.000

Review 7.  Sirtuins and their relevance to the kidney.

Authors:  Chuan-Ming Hao; Volker H Haase
Journal:  J Am Soc Nephrol       Date:  2010-07-01       Impact factor: 10.121

8.  Stage-specific quantitative changes in renal and urinary proteome during the progression and development of streptozotocin-induced diabetic nephropathy in rats.

Authors:  Vikram Sharma; Kulbhushan Tikoo
Journal:  Mol Cell Biochem       Date:  2013-11-27       Impact factor: 3.396

9.  Role of sirtuin histone deacetylase SIRT1 in prostate cancer. A target for prostate cancer management via its inhibition?

Authors:  Brittney Jung-Hynes; Minakshi Nihal; Weixiong Zhong; Nihal Ahmad
Journal:  J Biol Chem       Date:  2008-12-15       Impact factor: 5.157

10.  Change in post-translational modifications of histone H3, heat-shock protein-27 and MAP kinase p38 expression by curcumin in streptozotocin-induced type I diabetic nephropathy.

Authors:  K Tikoo; R L Meena; D G Kabra; A B Gaikwad
Journal:  Br J Pharmacol       Date:  2008-01-21       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.